A Peek Behind the Numbers

A Peek Behind the Numbers

Share this post

A Peek Behind the Numbers
A Peek Behind the Numbers
Unpacking Doximity’s (DOCS) Q4 Numbers

Unpacking Doximity’s (DOCS) Q4 Numbers

Guidance disappoints and temporary factors still at play

Behind the Numbers's avatar
Behind the Numbers
Jun 12, 2025
∙ Paid
1

Share this post

A Peek Behind the Numbers
A Peek Behind the Numbers
Unpacking Doximity’s (DOCS) Q4 Numbers
1
Share

In our April 17th report on Doximity's (DOCS) 3Q'25 results — A Peek Behind Doximity's Numbers— we highlighted several accounting-related factors that were temporarily boosting the company's financial performance. On May 15, DOCS reported non-GAAP EPS of $0.38, beating Street estimates by 11 cents. Revenue reached $138.3 million, exceeding consensus by $4.3 million.

Despite these headline beats, the company issued disappointing forward guidance. Management projected just 9% revenue growth for Q1'26 and 9%–14% for fiscal 2026 — a sharp slowdown from the 17% growth reported in 4Q. The outlook also included a modest decline in adjusted EBITDA margins for Q1 and only 3 cents of year-over-year growth in adjusted EPS.

We remain concerned that Doximity's addressable market is becoming saturated. The company noted in its 10-K that 620,000 unique providers were actively using its creative workflow tools, up just 6.9% from 580,000 a year earlier. Given that DOCS already reaches over 80% of US physicians, future user growth may be increasingly difficult to achieve.

Our analysis of the 4Q'25 results suggests that temporary and nonrecurring factors are still boosting DOCS's reported sales and earnings — and that these factors more than account for the company's 11-cent EPS beat. We explore these issues below.


This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Behind the Numbers
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share